Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced the pricing of the previously announced underwritten secondary offering of 45,000,000 shares of the Company's common stock (the "Offering") held by certain of its stockholders pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission, at the public offering price of $16.25 per share.

In connection with the Offering, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to an additional 6,750,000 shares of common stock on the same terms and conditions. No shares are being sold by the Company. The Selling Stockholders will receive all of the proceeds from this offering.

Goldman Sachs & Co. LLC and J.P. Morgan are serving as the joint book-running managers and as representatives of the underwriters for the offering. Guggenheim Securities and Jefferies are acting as co-managers for the offering.

About Avantor

Avantor® is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. We operate in more than 30 countries and deliver an extensive portfolio of products and services. We set science in motion to create a better world.